http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019351011-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e4790c814adc8c5a88802341d396009 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-15 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-15 |
| filingDate | 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5835a8b438bf1f91999f33c8cc44263 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f82c2934a49b6ccfd7133348b38220 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9223223f6cace0b6c3553d227ea7191e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f45986681ec493c2773dd11b6dc0f3de |
| publicationDate | 2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2019351011-A1 |
| titleOfInvention | Pharmaceutical composition for anti-angiogenesis containing cyclic pentadepsipeptide as an effective ingredient |
| abstract | The present invention relates to a composition for inhibiting angiogenesis, containing neo-N-methylsansalvamide (NMSSV), which is a cyclic pentadepsipeptide, as an effective ingredient, and specifically, since the NMSSV of the present invention has excellent activity which inhibits cell migration and tube formation associated with angiogenesis, and concentration-dependently inhibits angiogenesis induced by a vascular endothelial growth factor, it is expected that the NMSSV of the present invention may inhibit angiogenesis and be usefully used as a therapeutic agent for various diseases in which angiogenesis is abnormally regulated. |
| priorityDate | 2017-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 233.